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The exponential growth in interventional cardiology has
been the result of 1) changes in patient selection criteria from
stable angina pectoris to acute ischemic syndromes and from
single to multivessel disease; 2) changes in technology that
have allowed easier and safer dilation (coronary angioplasty)
of more complex arterial lesions; and 3) wide acceptance of
angioplasty by physicians and patients alike based on grow-
ing experience with safety and efficacy. A fourth reason for
the increase in the number of procedures performed has
been the increase in patients returning with restenosis.
Postangioplasty restenosis. There are many important is-
sues surrounding restenosis (1-3). These include 1) definition
of restenosis. There are multiple arbitrary definitions of
restenosis including an absolute change in stenosis severity,
loss of some of the initial gain, a final residual stenosis of
>50% to 70%, or absolute diameter changes (1,3).
2) Pathophysiology (4). There is limited information
about human coronary restenosis, derived mainly from
descriptive autopsy findings in small numbers of patients
who have had prior angioplasty. With the development and
use of atherectomy, we have had the chance to study more
closely the nature and spectrum of restenosis. More re-
cently, a laboratory model of restenosis has been developed
that reproducibly yields animal restenosis and appears to be
identical to human restenotic tissue.
3) Incidence and timing ofrestenosis. There has been an
increasing amount of data dealing with this important issue.
The initial large observational National Heart, Lung, and
Blood Institute PTCA Registry documented restenosis in
approximately 30% of patients undergoing follow-up angiog-
raphy (I). This incidence has been surprisingly similar in
many subsequent studies dealing mainly with patients with
single vessel disease. With multivessel disease, the inci-
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dence may be even higher. Elegant serial follow-up angio-
graphic studies have further characterized the timing and
incidence of restenosis (2,3). In most of these studies,
restenosis becomes clinically or angiographically evident by
3 to 6 months.
4) Identification ofpatients at riskfor restenosis. This is
an exceedingly important issue. Multiple other studies have
documented baseline demographic descriptors and proce-
dural variables associated with an increased incidence of
restenosis. These imply only association and not causation
and, for a specific patient, J;I1ay not serve to identify a very
high likelihood of the event. If we could identify patients
with a high likelihood of developing restenosis or, con-
versely, a very low likelihood, alternative follow-up plans
might be developed to optimize their care.
Current study. The current report by EI-Tamimi, et al.
(5) in this issue of the Journal deals with this important
detection issue in a group of 31 patients with single vessel
disease, chronic stable angina pectoris, and positive exercise
test who underwent successful coronary dilation. Treadmill
exercise tests were performed without antianginal therapy
before angioplasty, and repeated at 3 days, and 1, 3 and
finally 6 months after angioplasty. In patients with a positive
exercise test, the test was repeated 1 h later after adminis-
tration of 10 mg of intravenous verapamil. The patients were
separated into two groups on the basis of the coronary
angiogram; Group 1 (17 patients, 55%) had no restenosis,
whereas Group 2 (14 patients, 45%) had restenosis. The
residual stenosis immediately after angioplasty was similar
in both groups.
In Group 1, all 17 patients had a normal exercise test,
with the exception of 3 patients who had a positive test at 3
days only, which then normalized for the remaining follow-
up tests. In Group 2 patients, those who developed resteno-
sis, the results were quite different. At 3 days, the exercise
test was positive in 11 of 14. At 1, 3 and 6 months, the
exercise test was positive in 13 of 14 patients.
The use of noninvasive tests to predict or identify reste-
nosis is not new; there have been several other publications
dealing with the use of treadmill exercise testing, multiple
acquisition gated blood pool scans or thallium scintigraphy
(6-9). It is of interest that in other studies, using more
sophisticated techniques, the excellent negative predictive
nature of a normal test has been documented; however, the
predictive value of a positive test has been less satisfactory.
It may be that the results in the present study were, in part,
dependent on the small number of patients studied. Another
possibility relates to the study group. In that regard, it must
be remembered that the results of this study apply only to
those patients studied, i.e., those with single vessel disease
and chronic stable angina. In many institutions, the majority
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of patients undergoing dilation have multivessel disease; in
such patients, exercise testing may not be as helpful. Thus,
more sophisticated tests or follow-up angiography may be
required to identify significant restenosis.
The timing of the follow-up test also has important
implications for scheduling follow-up. EI-Tamimi et al. (5)
document that by 3 days the majority of patients with
restenosis already had a positive exercise test. Therefore,
patients can be evaluated soon after angioplasty, and subse-
quent follow-up can be scheduled appropriately. This early
"positivity" finding also has important implications about
potential mechanisms of restenosis. The authors note that
the postangioplasty residual stenosis was similar in patients
with and without restenosis, a finding that would lead one to
think that inadequate initial dilation was not the important
variable here. However, the role of angiography as a "gold
standard" to assess the severity of stenoses has been tar-
nished, at the very least. It may be that, in the patients with
restenosis, the initial postangioplasty angiogram merely un-
derestimated the functional degree of stenosis. More likely
would be elastic recoil or platelet thrombus deposition and
local vasoconstriction. The latter is supported by the finding
that, in four of six patients who had a positive exercise test
at 3 days after angioplasty, the test became negative after
verapamil. Whether this effect is related to dynamic changes
in epicardial vessels or changes in resistance in smaller
vessels cannot be determined.
Implications. What, then, can we learn from the present
study? The most important message affects patients with
single vessel disease and stable angina who do not have
baseline electrocardiographic abnormalities that preclude
interpretation of the results of exercise testing. In this group,
the inexpensive treadmill exercise test can be used to predict
patients who have little chance of developing restenosis or,
conversely, have a high likelihood of restenosis. More
sophisticated and expensive tests (for example, radionuclide
studies) are not needed in these patients. For the larger
group of patients, those with multivessel disease or ECG
abnormalities at rest that interfere with interpretation of the
stress electrocardiogram, the answer is not in. It is hoped
that, in other similarly focused controlled studies, these
larger concerns will be addressed.
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